BIOVENTUS INC. - CLASS

Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

11 авг 2022 07:00:03 Источник Nasdaq GlobeNewswire

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite  

03 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

26 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

Bioventus Completes CartiHeal Acquisition

12 июл 2022 08:30:00 Источник Nasdaq GlobeNewswire

Bioventus Amends CartiHeal Acquisition Structure

21 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

10 май 2022 07:00:04 Источник Nasdaq GlobeNewswire

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

03 май 2022 17:47:17 Источник Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

02 май 2022 07:00:01 Источник Nasdaq GlobeNewswire

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

26 апр 2022 09:05:09 Источник Nasdaq GlobeNewswire

Bioventus Announces $415 Million Offering of Senior Notes

26 апр 2022 08:38:49 Источник Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

25 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

08 апр 2022 09:15:08 Источник Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

05 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire

Bioventus Exercises Call Option to Acquire CartiHeal

04 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference

16 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

10 мар 2022 07:00:03 Источник Nasdaq GlobeNewswire

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

01 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Bioventus Appoints Mark Singleton as Chief Financial Officer

28 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

22 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

11 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire